Columbia Asset Management Gilead Sciences, Inc. Transaction History

Columbia Asset Management

$574 Million
Q3 2024

A detailed history of Columbia Asset Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Columbia Asset Management holds 3,910 shares of GILD stock, worth $362,848. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,910

Previous 3,910 -0.0%

Holding current value

$362,848

Previous $268,000 22.39%

% of portfolio

0.06%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $3,663 - $4,154	50 Added 1.3%	3,910 $317,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $6,284 - $6,856	-85 Reduced 2.15%	3,860 $289,000
Q2 2022 Aug 26, 2022	SELL	$57.72 - $65.01 $263,087 - $296,315	-4,558 Reduced 53.6%	3,945 $244,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $145,785 - $165,469	-2,247 Reduced 20.9%	8,503 $617,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $100,993 - $108,960	1,492 Added 16.12%	10,750 $751,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $85,176 - $93,067	1,342 Added 16.95%	9,258 $637,000
Q1 2021 May 28, 2021	BUY	$60.0 - $68.46 $183,480 - $209,350	3,058 Added 62.95%	7,916 $512,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $169 - $193	3 Added 0.06%	4,858 $283,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $313,418 - $394,069	-5,047 Reduced 50.97%	4,855 $307,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $318,947 - $370,356	-4,409 Reduced 30.81%	9,902 $762,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $450,622 - $577,182	7,195 Added 101.11%	14,311 $1.07 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $41,593 - $45,751	675 Added 10.48%	7,116 $4.62 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $15,627 - $17,250	250 Added 4.04%	6,441 $408,000
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $162,718 - $182,469	2,630 Added 73.86%	6,191 $418,000
Q1 2019 May 20, 2019	SELL	$62.53 - $70.05 $6,253 - $7,005	-100 Reduced 2.73%	3,561 $232,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $36,324 - $47,400	-600 Reduced 14.08%	3,661 $229,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $194,640 - $227,040	-3,000 Reduced 41.32%	4,261 $302,000
Q1 2018 May 07, 2018	BUY	$72.84 - $88.8 $107,439 - $130,980	1,475 Added 25.49%	7,261 $547,000
Q4 2017 Feb 05, 2018	BUY	$71.15 - $83.52 $24,902 - $29,232	350 Added 6.44%	5,786 $415,000
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $391,989 - $464,614	5,436	5,436 $440,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Gilead Sciences, Inc. Transaction History